AI assistant
Sending…
GENTEX CORP — Director's Dealing 2021
Feb 4, 2021
30893_dirs_2021-02-04_6b86a8bd-e278-4660-8c78-d6ab9dbb5b0b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GENTEX CORP (GNTX)
CIK: 0000355811
Period of Report: 2021-02-01
Reporting Person: Wallace James H (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-02-01 | Common Stock | M | 7000.00 | $14.30 | Acquired | 32864.00 | Direct |
| 2021-02-01 | Common Stock | S | 7000.00 | $33.8981 | Disposed | 25864.00 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-02-01 | Employee Stock Option (Right to buy) | $14.30 | M | 7000.00 | Disposed | 2024-05-15 | Common Stock (7000.00) | Direct |
Footnotes
F1: This transaction was executed in multiple trades at prices ranging from $33.82 to $33.94. The price reported above reflects the weighted average sale price.
More from GENTEX CORP
Interim / Quarterly Report
2026
May 6
Major Shareholding Notification
2026
Apr 30
Regulatory Filings
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Feb 24
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19